Sign in

CIK 0001896212

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

CDT Equity Inc.

Sign in to watch
Ticker
CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
873272543
Phone
+1 646-491-9132
Business address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
Former names
CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.

Securities

  • CDT Common Stock Nasdaq
  • CDTTW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 2 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Taylor Mark Andrew 10% owner Sale −5,000 $0.71 $4K 1,464,711
2026-06-18 Taylor Mark Andrew 10% owner Sale −1,464,711 $1.44 $2.1M 0
2026-06-18 Taylor Mark Andrew 10% owner Sale −5,000 $0.75 $4K 593,289
2026-06-18 Taylor Mark Andrew 10% owner Sale −593,289 $1.40 $829K 0
2026-03-17 Taylor Mark Andrew 10% owner Other acquisition +51,420,358 51,700,014
2026-03-17 Taylor Mark Andrew 10% owner Other disposition · Pre-Funded Warrants −51,161,318 0
2026-02-19 Taylor Mark Andrew 10% owner Other disposition −46,902 279,656
2026-02-19 Taylor Mark Andrew 10% owner Other disposition · Pre-Funded Warrants −9,968,931 14,609,501

Page 1 of 1 · 8 trades